Pavan Puligujja
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 5
- HIV/AIDS Research and Interventions 4
- Tuberculosis Research and Epidemiology 1
- Virology 7
- HIV Research and Treatment 7
- Co-authors
- Howard E. Gendelman (10 shared papers)Xin-Ming Liu (6 shared papers)JoEllyn McMillan (5 shared papers)Shantanu Balkundi (4 shared papers)Benson Edagwa (5 shared papers)Nathan Smith (3 shared papers)Dongwei Guo (3 shared papers)Nagsen Gautam (3 shared papers)
- Journals
- Nanomedicine (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Nanomedicine Nanotechnology Biology and Medicine (1 paper)Biomaterials (1 paper)The FASEB Journal (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Pavan Puligujja
10 papers receiving 336 citations
Peers
Comparison fields: 5 of 49
- Virology 150
- Infectious Diseases 161
- Emergency Medicine 46
- Pharmaceutical Science 35
- Biomaterials 46
Countries citing papers authored by Pavan Puligujja
This map shows the geographic impact of Pavan Puligujja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pavan Puligujja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pavan Puligujja more than expected).
Fields of papers citing papers by Pavan Puligujja
This network shows the impact of papers produced by Pavan Puligujja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pavan Puligujja. The network helps show where Pavan Puligujja may publish in the future.
Co-authors
The 25 scholars most cited alongside Pavan Puligujja, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 73 | |
| 2 | 2013 | 68 | |
| 3 | 2014 | 57 | |
| 4 | 2014 | 40 | |
| 5 | 2018 | 23 | |
| 6 | 2014 | 20 | |
| 7 | 2015 | 19 | |
| 8 | 2015 | 19 | |
| 9 | 2015 | 12 | |
| 10 | 2013 | 10 |
About Pavan Puligujja
Pavan Puligujja is a scholar working on Infectious Diseases, Virology, Emergency Medicine, Pharmaceutical Science and Epidemiology, having authored 10 papers that have together received 341 indexed citations. Recurring topics across this work include HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (5 papers), HIV/AIDS Research and Interventions (4 papers), HIV-related health complications and treatments (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper), Tuberculosis Research and Epidemiology (1 paper), Nanoparticle-Based Drug Delivery (1 paper) and Advanced Drug Delivery Systems (1 paper). The work is most often cited by research in Virology (150 citations), Infectious Diseases (161 citations), Emergency Medicine (46 citations), Pharmaceutical Science (35 citations) and Biomaterials (46 citations). Pavan Puligujja has collaborated with scholars based in United States and China. Frequent co-authors include Howard E. Gendelman, Xin-Ming Liu, JoEllyn McMillan, Shantanu Balkundi, Benson Edagwa, JoEllyn McMillan, Nathan Smith, Dongwei Guo, Nagsen Gautam and Yazen Alnouti. Their work appears in journals such as Nanomedicine, Antimicrobial Agents and Chemotherapy, Nanomedicine Nanotechnology Biology and Medicine, Biomaterials and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.